Back to the program

Contributed

Treatment & Clinical Outcomes

Fri, Jan 15, 8:30 AM - 10:15 AM

6 Abstracts

Expanded Access to Direct-Acting Antivirals for Hepatitis C Virus Treatment in Tennessee After Authorization of Non-Specialist Provider Prescribing in Medicaid

Ahra Kim (Vanderbilt University)

Co-authors: Cody A. Chastain (Vanderbilt University Medical Center), Carrie Fry (Vanderbilt University), Ashley A. Leech (Vanderbilt University), Peter F. Rebeiro (Vanderbilt University), Andrew D. Wiese (Vanderbilt University)

access to treatment healthcare access population health infectious disease hepatitis c virus HCV interrupted time series

The Effect of Opioid Abatement Funds on Medication-Assisted Treatment Utilizations for Opioid Use Disorder

Opioids Substance Use Disorder Medications for Opioid Use Disorder Health Policy Analysis

Estimating U.S. Prescription Acetaminophen Exposure, 2001–2023: A Standardized MEPS-Based Denominator for Policy Evaluation and Pharmacovigilance

acetaminophen prescription MEPS exposure denominator pharmacovigilance regulatory intervention policy evaluation

Unifying healthcare free days and multistate models: mean restricted health state outcomes for competing risks in oncology care delivery trials

Nina Galanter (Memorial Sloan Kettering Cancer Center)

Co-authors: Katherine Panageas (Memorial Sloan Kettering Cancer Center)

competing risks care delivery clinical trials oncology composite outcomes

New Precise Formulation of Minimally Important Change for Patient-Reported Outcomes: A Dilemma and a New Estimator

Hongxiang Qiu (Michigan State University)

Minimally important change minimally clinically important difference meaningful within-patient change patient-reported outcome responder anchor-based methods

Impact of Hurricane Florence on Buprenorphine Transactions for Opioid Use Disorder: A Dual-Perspective Synthetic Control Study

Eva Murphy (Baylor University)

Co-authors: Meredith C.B. Adams (Wake Forest University School of Medicine), Collin Cademartori (Wake Forest University), Staci Hepler (Wake Forest University), Robert Hurley (Wake Forest University School of Medicine), David Kline (Wake Forest University School of Medicine), Cara L McDonnell (Atrium Health Wake Forest Baptist), Jae Yong (Wake Forest University School of Medicine)

Extreme events Opioid use disorder Causal latent factor Generalized synthetic control

↑